Distribution of rotavirus genotypes after introduction of rotavirus vaccines, rotarix® and rotateq®, into the national immunization program of Australia

Pediatric Infectious Disease Journal

Volumn 30, Issue SUPPL. 1, 2011, Pages

  Kirkwood, Carl D ^a   Boniface, Karen ^a   Barnes, Graeme L ^a   Bishop, Ruth F ^a  

^a ROYAL CHILDREN'S HOSPITAL   (Australia)

Author keywords

Australia; Rotarix rotavirus; RotaTeq; strain; surveillance

Indexed keywords

ROTAVIRUS VACCINE;

ARTICLE; AUSTRALIA; CHILD; CHILD HOSPITALIZATION; GENOTYPE; GEOGRAPHIC DISTRIBUTION; HUMAN; INFECTIOUS DIARRHEA; MAJOR CLINICAL STUDY; PREVENTIVE HEALTH SERVICE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; ROTAVIRUS; ROTAVIRUS INFECTION; SEASONAL VARIATION; VIRUS GENE; VIRUS IMMUNITY; VIRUS STRAIN;

AUSTRALIA; CHILD; CHILD, PRESCHOOL; DIARRHEA; FECES; GENOTYPE; HOSPITALIZATION; HUMANS; IMMUNIZATION PROGRAMS; MOLECULAR EPIDEMIOLOGY; PREVALENCE; ROTAVIRUS; ROTAVIRUS INFECTIONS; ROTAVIRUS VACCINES; VACCINES, ATTENUATED;

EID: 78751475831     PISSN: 08913668     EISSN: 15320987     Source Type: Journal    
DOI: 10.1097/INF.0b013e3181fefd90     Document Type: Article

References (39)

1. Parashar UD, Gibson CJ, Bresee JS, et al. Rotavirus and severe childhood diarrhea. Emerg Infect Dis. 2006;12:304-306.
2. Carlin J, Chondros P, Masendycz P, et al. Rotavirus infection and rates of hospitalisation for acute gastroenteritis in young children in Australia, 1993-1996. Med J Aust. 1998;169:252-256.
3. Galati JC, Harsley S, Richmond P, et al. The burden of rotavirus-related illness among young children on the Australian health care system. Aust N Z J Public Health. 2006;30:416-421.
4. Vesikari T, Matson DO, Dennehy P, et al. Rotavirus Efficacy and Safety Trial (REST) Study Team. Safety and efficacy of a pentavalent human-bovine (WC3) reassortant rotavirus vaccine. N Engl J Med. 2006;354: 23-33.
5. Ruiz-Palacios GM, Perez-Schael I, Velazquez FR, et al. Human Rotavirus Vaccine Study Group. Safety and efficacy of an attenuated vaccine against severe rotavirus gastroenteritis. N Engl J Med. 2006;354:11-22.
6. Estes MK, Kapikian AZ. Rotaviruses. In: Knipe DM, Howley PM, Griffin DE, et al, eds. Fields Virology. Vol 2. 5th ed. Philadelphia: Lippincott Williams & Wilkins; 2007:1917-1974.
7. Matthijnssens J, Bilcke J, Ciarlet M, et al. Rotavirus disease and vaccination: impact on genotype diversity. Future Microbiol. 2009;4:1303-1316.
8. Gentsch JR, Laird AR, Bielfelt B, et al. Serotype diversity and reassortment between human and animal rotavirus strains: implications for rotavirus vaccine programs. J Infect Dis. 2005;192(suppl 1):S146-S159.
9. Santos N, Hoshino Y. Global distribution of rotavirus serotypes/genotypes and its implication for the development and implementation of an effective rotavirus vaccine. Rev Med Virol. 2005;15:29-56.
10. Ward RL, Bernstein DI. Rotarix: a rotavirus vaccine for the world. Clin Infect Dis. 2009;48:222-228.
11. Heaton PM, Ciarlet M. Vaccines: the pentavalent rotavirus vaccine: discovery to licensure and beyond. Clin Infect Dis. 2007;45:1618-1624.
12. Boom JA, Tate JE, Sahni LC, et al. Effectiveness of pentavalent rotavirus vaccine in a large urban population in the United States. Pediatrics. 2010;125:e199-e207.
13. Richardson V, Hernandez-Pichardo J, Quintanar-Solares M, et al. Effect of rotavirus vaccination on death from childhood diarrhea in Mexico. N Engl J Med. 2010;362:299-305.
14. Madhi SA, Cunliffe NA, Steele D, et al. Effect of human rotavirus vaccine on severe diarrhea in African infants. N Engl J Med. 2010;362:289-298.
15. Australian Government Department of health and Aging. Fact sheet: Australian Government funding of rotavirus vaccine. Available at: http://www.health.gov.au/internet/main/publishing.nsf/content/rotavirus-vaccine. htm.
16. Iturriza-Gómara M, Kang G, Gray J. Rotavirus genotyping: keeping up with an evolving population of human rotaviruses. J Clin Virol. 2004;31:259-265.
17. Simmonds MK, Armah G, Asmah R, et al. New oligonucleotide primers for P-typing of rotavirus strains: strategies for typing previously untypeable strains. J Clin Virol. 2008;42:368-373.
18. Gouvea V, Glass R, Woods P, et al. Polymerase chain reaction amplification and typing of rotavirus nucleic acid from stool specimens. J Clin Microbiol. 1990;28:276-282.
19. Gentsch JR, Glass RI, Woods P, et al. Identification of group A rotavirus gene 4 types by polymerase chain reaction. J Clin Microbiol. 1992;30: 1365-1373.
20. Kirkwood CD, Boniface K, Bogdanovic-Sakran N, et al. Rotavirus strain surveillance-an Australian perspective of strains causing disease in hospitalized children from 1997 to 2007. Vaccine. 2009;27(suppl 5):F102-F107.
21. Macartney K, Burgess M. Rapid impact of rotavirus vaccination in USA- implications for Australia. Med J Aust. 2009;191:131-132.
22. Belshaw DA, Muscatello DJ, Ferson MJ, et al. Rotavirus vaccination one year on. Commun Dis Intell. 2009;33:337-340.
23. Lambert SB, Faux CE, Hall L, et al. Early evidence for direct and indirect effects of the infant rotavirus vaccine program in Queensland. Med J Aust. 2009;191:157-160.
24. Curns AT, Steiner CA, Barrett M, et al. Reduction in acute gastroenteritis hospitalizations among us children after introduction of rotavirus vaccine: analysis of hospital discharge data from 18 US States. J Infect Dis. 2010;201:1617-1624.
25. Centers for Disease Control and Prevention (CDC). Reduction in rotavirus after vaccine introduction-United States, 2000-2009. MMWR Morb Mortal Wkly Rep. 2009;58:1146-1149.
26. Clark HF, Lawley D, Mallette LA, et al. Decline in cases of rotavirus gastroenteritis presenting to The Children's Hospital of Philadelphia after introduction of a pentavalent rotavirus vaccine. Clin Vaccine Immunol. 2009;16:382-386.
27. Bishop RF, Masendycz PJ, Bugg HC, et al. Epidemiological patterns of rotaviruses causing severe gastroenteritis in young children throughout Australia from 1993 to 1996. J Clin Microbiol. 2001;39:1085-1091.
28. Gurgel RQ, Cuevas LE, Vieira SC, et al. Predominance of rotavirus P[4]G2 in a vaccinated population, Brazil. Emerg Infect Dis. 2007;13:1571-1573.
29. Carvalho-Costa FA, Araujo IT, Santos de Assis RM, et al. Rotavirus genotype distribution after vaccine introduction, Rio de Janeiro, Brazil. Emerg Infect Dis. 2009;15:95-97.
30. Gentsch JR, Hull JJ, Teel EN, et al. G and P types of circulating rotavirus strains in the United States during 1996-2005: nine years of pre-vaccine data. J Infect Dis. 2009;200(suppl 1):S99-S105.
31. Nakagomi T, Chang BR, Nakagomi O. Rotavirus hospitalization and molecular epidemiology in northern Japan, 1987-1996. Vaccine. 2009; 27(suppl 5):F93-F96.
32. Orozco M, Vasquez J, Pedreira C, et al. Uptake of rotavirus vaccine and national trends of acute gastroenteritis among children in Nicaragua. J Infect Dis. 2009;200(suppl 1):S125-S130.
33. Antunes H, Afonso A, Iturriza M, et al. G2P[4] the most prevalent rotavirus genotype in 2007 winter season in an European non-vaccinated population. J Clin Virol. 2009;45:76-78.
34. Iturriza-Gomara M, Dallman T, Banyai K, et al. Rotavirus surveillance in Europe, 2005-2008: web-enabled reporting and real-time analysis of genotyp-ing and epidemiological data. J Infect Dis. 2009;200(suppl 1):S215-S221.
35. Payne DC, Szilagyi PG, Staat MA, et al. Secular variation in United States rotavirus disease rates and serotypes: implications for assessing the rotavirus vaccination program. Pediatr Infect Dis J. 2009;28:948-953.
36. Correia JB, Patel MM, Nakagomi O, et al. Effectiveness of monovalent rotavirus vaccine (Rotarix) against severe diarrhea caused by serotypi-cally unrelated G2P[4] strains in Brazil. J Infect Dis. 2010;201:363-369.
37. Hull JJ, Teel EN, Kerin TK, et al. United States rotavirus surveillance from 1996-2008. Presented at: American Society for Virology, Annual Meeting; July 11-15, 2009; Vancouver, Canada. Abstract P37-2.
38. Ngo TC, Nguyen BM, Dang DA, et al. Molecular epidemiology of rotavirus diarrhea among children in Haiphong, Vietnam: the emergence of G3 rotavirus. Vaccine. 2009;27(suppl 5):F75-F80.
39. Xu J, Yang Y, Sun J, et al. Molecular epidemiology of rotavirus infections among children hospitalized for acute gastroenteritis in Shanghai, China, 2001 through 2005. J Clin Virol. 2009;44:58-61.